-
Call for ASH Clinical News Associate Editors (2024-2026)
Interested in being an associate editor of ASH Clinical News? Apply today!
Online Exclusives
Editor's Corner
The Often-Inexplicable Turns of a Career in Hematology
June 2023
Andrew J. Cowan, MD
Dr. Cowan discusses the unpredictable journey that is a career in hematology. He addresses his experiences as a resident and fellow as well as interactions with mentors and the decision to pursue post-fellowship subspecialty training.
Advertisement
Most Read Articles
- Decitabine Yields Similar Survival Despite Superior Responses Versus HU in MP-CMML
- The United States of Medicine
- Consensus Guidelines Outline Treatment of ITP Related to SARS-CoV-2 Infection, Vaccination
- Machine Learning Algorithm Predicts Acquired Versus Inherited Bone Marrow Failure
- You Make the Call: When would you start phlebotomy for an asymptomatic patient with hemochromatosis?
Advertisement
Concurrent Pembrolizumab and AVD as Frontline Therapy in Untreated cHL
June 2023
In patients with untreated classical Hodgkin lymphoma, concurrent use of pembrolizumab and the chemotherapy combination of doxorubicin, vinblastine, and dacarbazine was shown to be safe and effective without clinically significant treatment delays.
More Structure, Rigor Needed in Peripheral Blood Smear Training
June 2023
Training in the review of peripheral blood smears in graduate hematology education should be done with a structured approach and with an emphasis on mastery of cases that could avert imminent clinical decompensation. Researchers convened a multi-institutional focus group to establish the core components of an assessment tool.
2022 ELN Genetic-Risk Stratification Does Not Predict Outcomes Better Than 2017 Stratification for Adults With AML
June 2023
Researchers conducted an analysis of adult patients diagnosed with de novo AML. They analyzed the correlation between genetic-risk stratification and patient outcomes, compared performance of the stratifications in age and ethnicity cohorts, and evaluated the prognostic potential of additions to the criteria used by the 2022 ELN genetic-risk stratification.